FDA Grants Breakthrough Designation for Axial Spondyloarthritis Diagnostic Test
The multiplex immunoassay measures autoantibodies to the 14-3-3eta protein and aims to reduce diagnostic delays that currently average seven to 10 years.
The multiplex immunoassay measures autoantibodies to the 14-3-3eta protein and aims to reduce diagnostic delays that currently average seven to 10 years.
A machine learning algorithm achieved 97% accuracy in diagnosing celiac disease from biopsy images, potentially improving diagnostic speed.
Augurex Life Sciences and ARUP Labs collaborated on a test to detect rheumatoid arthritis for improved early diagnostic capabilities.
A new study reveals that 80% of asthma patients suffer from allergic rhinitis, with significant skin test reactivity to various allergens.
Read MoreNew research links specific genetic mutations to subsets of lupus patients, enabling personalized treatments that target toll-like receptors.
Read MoreAMPEL BioSolutions’ predictive AI-driven blood test for Lupus forecasts patient flares and drug targets from gene expression.
Read MoreThe personal journey of co-author and physician Dana Mitchell details the challenges of accurate diagnosis of autoimmune encephalitis.
Read MoreThe emerging Powassan virus in ticks can cause life-threatening neuroinvasive disease, including encephalitis and meningitis.Â
Read MoreThe FDA has cleared Xpert Xpress GBS, a dual-target molecular diagnostic test for the qualitative intrapartum detection of GBS.
Read MoreNew studies have added at least six novel urine biomarkers of active renal lupus validated across two ethnically diverse patient cohorts
Read MoreSavara Inc. recently a new serum-based blood test that can be used by physicians to obtain a definitive diagnosis of aPAP.
Read MoreThermo Fisher Scientific signed a distribution agreement with Aesku to market, sell, and support their portfolio of IFA products in the U.S.
Read MoreQuest and Scipher Medicine will collaborate to expand access to diagnostic services advancing precision medicine for rheumatoid arthritis.
Read MoreAqtual demonstrated its platform can identify synovial gene expression signatures in patients with rheumatoid arthritis using a blood test.Â
Read MoreMayo Clinic’s new collaboration will bring Progentec’s suite of biomarker blood tests for the management of autoimmune diseases to market.Â
Read MoreResearchers reported for the first time that a genetic biomarker may be able to help predict the severity of food allergy reactions.Â
Read MoreResearchers from the University of Houston are working to bring AI into the diagnostic picture for Lupus Nephritis.
Read MoreResearchers at the University of Basel and the University Hospital of Basel described a possible new MS-like disease and how to diagnose it.
Read More